Krebs Biochemicals & Industries Ltd. Financial Overview
Krebs Biochemicals & Industries Ltd.'s market cap is currently ₹1.51B. The company's EPS TTM is ₹-2.849; its P/E ratio is -5.48; Krebs Biochemicals & Industries Ltd. is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
